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In unstimulated rat islets (2 mM glucose), most of the ion-exchange purified protein kinase C (PKC) activity was associat- 
ed with the cytosolic fraction. Both carbachol and phorbol myristate acetate caused a significant ranslocation of PKC 
activity from cytosolic to membrane fractions, but under the same conditions, glucose (20 mM) did not cause such a 
redistribution of PKC activity. PMA-induced translocation of PKC to the membrane fraction was also observed in elec- 
trically permeabilised islets, in which recovery of the enzyme activity was enhanced by buffering the intracellular Ca2+ 
concentration to SO nM and supplying the permeabilised islets with protease inhibitors. 
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1. INTRODUCTION 
Protein kinase C (PKC) is a closely related fami- 
ly of Ca2+- and phospholipid-dependent kinases 
which have been identified in a wide range of 
tissues [l]. At physiological concentrations of 
Ca’+, PKC can be activated by increases in the in- 
tracellular availability of diacylglycerols (DAG), 
or by tumour-promoting phorbol esters, such as 
phorbol myristate acetate (PMA), which can 
substitute for DAG [1,2]. 
PKC has been identified and characterised in 
islets of Langerhans and insulin-secreting tumour 
cells [3,4], and DAG analogues [S] or phorbol 
esters [6,7] have been shown to stimulate insulin 
secretion in vitro. However, the precise 
physiological role of PKC in the control of insulin 
secretion in response to nutrient secretagogues 
(e.g. glucose) or receptor-mediated secretagogues 
(e.g. cholinergic muscarinic agonists) is still 
uncertain. 
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The activation of PKC is thought to involve 
translocation of the enzyme from the cytosol to 
membranes, where it associates with phos- 
phatidylserine forming a catalytically active com- 
plex [8]. We have therefore determined the effects 
of glucose, PMA and the muscarinic agonist 
carbachol (CCh) on the distribution of PKC ac- 
tivity between cytosolic and membrane fractions 
prepared from isolated rat islets of Langerhans. 
2. MATERIALS AND METHODS 
2.1. Materials 
Collagenase (type Xl), bovine serum albumin (BSA, fraction 
V), leupeptin, phenylmethylsulphonyl fluoride (PMSF), PMA, 
CCh, Nonidet P-40, diolein, phosphatidylserine, histone type 
Ills and adenosine 5 ‘-triphosphate (ATP) were obtained from 
Sigma (England). Tissue culture medium was from Gibco 
(Europe). [y-‘sP]ATP (3000 Ci/mmol) was from Amersham 
International (England). All other reagents were of analytical 
grade from BDH (England). 
2.2. Islet isolation and permeabilisation 
Islets of Langerhans were isolated from fed Wistar rats of 
either sex (150-200 g) by collagenase digestion of the pancreas 
[9] and maintained in a bicarbonate-buffered (pH 7.4) 
physiological salt solution (Gey-Gey buffer [IO]) supplemented 
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with 2 mM glucose, 2 mM CaClz and 0.5 mg/ml BSA. To 
determine the effects of CCh on the intracellular distribution of 
PKC, islets were first cultured for 20 h at 37’C in RPM1 1640 
in a humidified atmosphere of 5% CO2/95o/a 02 to facilitate 
receptor egeneration. In some experiments insulin secretion in- 
to the supernatant (5 islets/O.5 ml) was measured by radioim- 
munoassay [1 l] and in others, islets were electrically 
permeabilised as in [7,12]. For permeabilisation, islets were 
thoroughly washed in a K+-glutamate-based Ca2+/EGTA buf- 
fer (permeation buffer, pH 6.6) with CaCl2 added to give a free 
Ca2+ concentration of 50 nM, then permeabilised by 5 ex- 
posures (200 AS) to an electric field of 3.4 kV/cm. A modified 
permeation buffer, containing 50rg/ml leupeptin and 1 mM 
PMSF, was used for incubation of permeabilised islets. 
2.3. Extraction and partial purification of PKC 
Groups of 300-450 islets were incubated for 5 min, unless 
otherwise indicated, at 37°C in 200~1 of appropriate buffer 
(Gey-Gey buffer supplemented with 500 CM CCh, 500 nM 
PMA or 20 mM glucose for intact islets; modified permeation 
buffer supplemented with 500 nM PMA for permeabilised 
islets). Following incubation, islets were pelleted by a brief cen- 
trifugation (9000 x g, 15 s), the supernatant was discarded, and 
200~1 ice-cold buffer A (20 mM Tris-HCl, 2 mM EDTA, 
0.5 mM EGTA, 50 pg/ml leupeptin, 1 mM PMSF and 0.1% 
mercaptoethanol, pH 7.5) were added to the pellet. Islets were 
sonicated (MSE Soniprobe, 3 x 15 s, 4pm) and membranes 
were separated from the cytosol by centrifugation at 30000 x 
g for 15 min at 4°C. The resulting membrane pellets were 
dispersed by sonication (2 x 15 s, 4 pm) in 200 /tl buffer A and 
enzyme activity was solubilised by incubation (30 min, 4°C) in 
the presence of 1% Nonidet P-40. Membrane and supernatant 
fractions were applied to DEAE-cellulose DE52 columns 
(0.2 ml, pre-equilibrated with 1 ml buffer A) and the columns 
were washed with 3 ml buffer A. The enzyme was eluted from 
the columns using 300 gl buffer A supplemented with 120 mM 
NaCl. 
2.4. Protein kinase C assay 
PKC activity in eluate samples was assayed by measuring in- 
corporation of 32P from [y-“]ATP into histone type 111s. Ali- 
quots of the column eluates were incubated at 30°C in the 
presence of 11.1 mM magnesium acetate, 1.3 mM CaC12, 
96 @g/ml phosphatidylserine, 6.4 #g/ml diolein, 1.11 mg/ml 
histone and 111 PM ATP, in a final volume of 45 ~1. Reactions 
were started by the addition of [Y-~‘P]ATP (final spec. act. 
0.3 Ci/mmol), and terminated with 1 ml of cold 10% 
trichloroacetic acid containing 10 mM sodium pyrophosphate 
and 1 mM ATP. 5OOrg BSA were added as a carrier and the 
precipitated protein was collected onto Whatman GF/C filters 
using a Millipore 1225 filtration manifold, then washed four 
times with 5 ml of 5% trichloroacetic acid. “P incorporation 
was estimated by liquid scintillation counting of the filters 
(Beckman LS 7500). All samples were corrected for 32P binding 
to the filter in the absence of added enzyme activity (<0.2% 
total radiolabel). Each eluate sample was assayed in triplicate in 
the absence and presence of phosphatidylserine and diolein, and 
the difference in 32P incorporation between these conditions 
was taken to reflect PKC activity in the sample. Differences be- 
tween treatments were assessed by Student’s paired or unpaired 
t-tests, as appropriate. 
3. RESULTS 
In unstimulated islets (2 mM glucose) most of 
the PKC activity was associated with the cytosolic 
fraction (95.6 k 2% of total activity, mean + SE, 
n = 5), with little detectable activity in the mem- 
brane fraction (4.4 f 2% of total activity). Pro- 
gress curves in assays of PKC activity in both 
cytosolic and membrane fractions were linear with 
time for incubation periods of up to 10 min, as 
shown in fig.la. PKC activity was also dependent 
on enzyme concentration, showing a linear in- 
crease in activity with increasing volume of column 
eluate added to the incubation mixture, over the 
range 2.5-10~1 (fig.lb). For subsequent assays a 
sample volume of 10 ~1 column eluate and an in- 
cubation time of 10 min were used. 
The tumour-promoting phorbol ester, PMA, 
produced a redistribution of PKC activity in islets. 
Incubation of intact islets at 37°C in the presence 
of 500 nM PMA and 2 mM glucose caused a time- 
dependent decrease in cytosolic PKC activity with 
a maximal effect observed at 2 min, as shown in 
fig.2. Further exposure to PMA (up to 5 min) did 
not produce any further decrease in PKC activity 
associated with the cytosol (fig.2). The decrease in 
cytosolic PKC activity was accompanied by in- 
creased activity in the membrane fraction. Table 1 
(rows A) .shows the increase in membrane- 
associated PKC activity concomitant with a 
decrease in cytosolic activity in islets exposed to 
500 nM PMA for 5 min. The total amount of 
cellular PKC activity (cytosol plus membrane) was 
reduced following PMA-induced translocation of 
PKC activity. In four experiments in which islets 
were exposed to 500 nM PMA for 5 min, total 
PKC activity recovered was 77.5 + 4% of controls 
(no PMA). Since activated PKC is a substrate for 
a Ca’+-activated protease [2], this reduction in en- 
zyme activity may reflect proteolytic cleavage of 
PKC which had become activated and membrane- 
associated by the presence of PMA. We therefore 
measured the effects of PMA treatment on PKC 
distribution in electrically permeabilised islets, in 
which the protease inhibitors leupeptin and PMSF 
were introduced directly into the intracellular com- 
partment, and cytosolic Ca2+ was fixed at 50 nM 
by chelating buffers. As in intact islets, treatment 
of electrically permeabilised islets with 500 nM 
PMA for 5 min caused a significant reduction in 
81 




0 5 10 15 20 
Eluate volume (ul) 
Fig. 1. PKC activity in cytosol and membranes of unstimulated 
islets. (a) Ca”- and phospholipid-dependent PKC activity 
measured in cytosolic (0) and membrane (0) fractions 
prepared from unstimulated intact islets was linear with time up 
to incubation periods of 10 min. (b) Cytosolic PKC activity was 
concentration-dependent, showing a linear increase in activity 
over the range 2%104 of column eluate added per 
incubation. 
cytosolic PKC activity with a concomitant increase 
in the activity associated with the membrane frac- 
tion (table 1, rows B). In three such experiments 
the total PKC activity (cytosol plus membrane) 
recovered was 90.3 f 4% of control. 
A cholinergic muscarinic agonist had similar ef- 
fects to PMA on the distribution of PKC activity 
in intact islets. Incubation of cultured (20 h, 37°C) 
intact islets for 5 min at 37°C with 500 ,uM CCh at 
0 1 2 3 4 5 
Time (mid 
Fig.2. Time course of disappearance of PKC from cytosol in 
response to PMA. Incubation of intact islets in the presence of 
500 nM PMA (2 mM glucose) produced a time-dependent 
decrease in cytosolic PKC activity. 
Table 1 
Effects of PMA, CCh and glucose on redistribution of PKC 
activity 
PKC activity 
(fmol/islet per min) 
Cytosol Membrane 
(A) 2 mM glucose 275 + 19 undetectable 
2 mM glucose + 
500 nM PMA 140 + lob 43 f 7b 
(B) 50 nM Ca” 145* 5 11 *9 
50 nM Ca’+ + 500 nM PMA 80 + gb 47 f 4a 
(C) 2 mM glucose 225 f 21 14 + 6 
2 mM glucose + 5OOpM CCh 159 f 14” 46 + 5b 
(D) 2 mM glucose 320 f 27 undetectable 
20 mM glucose 300* 11 undetectable 
500 nM PMA caused a translocation of PKC activity from the 
cytosol to membranes in both intact (A) and electrically 
permeabilised (B) islets. 500 FM CCh had similar effects to 
PMA in intact islets (C), but under the same conditions 20 mM 
glucose was unable to cause a redistribution of PKC activity 
(D). Data are expressed as means f SE of 3-4 observations 
from single experiments (A-D), each representative of results 
obtained in 3-5 separate xperiments. Levels of significance by 
unpaired t-tests: ‘p < 0.05, bp < 0.01 vs appropriate PKC 
activity of unstimulated islets 
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a substimulatory glucose concentration (2 mM) 
produced a significant increase in membrane- 
associated PKC activity together with a reduction 
in enzyme activity in the cytosolic fraction, as 
shown in table 1 (rows C). 
In contrast, exposure of intact islets to 20 mM 
glucose for 5 min at 37°C did not cause a detec- 
table decrease in cytosolic PKC activity, or an in- 
crease in membrane-associated activity, compared 
to controls incubated in the presence of 2 mM 
glucose (table 1, rows D). In parallel experiments 
under the same conditions, 20 mM glucose caused 
a significant stimulation of insulin secretion from 
intact islets during a 5 min incubation at 37°C 
(2 mM glucose, 28.3 + 8 pg/islet per 5 min; 
20 mM glucose, 94.8 k 16, p < 0.01, n = 5). 
4. DISCUSSION 
Here, we have attempted to evaluate the involve- 
ment of PKC in receptor-mediated and glucose- 
induced insulin secretion by measuring the 
translocation of PKC from cytosol to membranes 
in isolated rat islets of Langerhans. In common 
with many other cell types [ 13- 161, exposing intact 
islets to a phorbol ester produced a detectable shift 
of PKC activity to the membrane fraction. Despite 
the relatively high concentrations of phorbol esters 
used in our experiments, the extent of PKC 
translocation in islets was less than that reported in 
other tissues [13,14], including a rat insulinoma 
cell line [16]. This appears to be a real difference 
between tissues, since we were able to show con- 
siderably more translocation of PKC activity in 
parallel experiments using rat anterior pituitary 
tissue (46% of total in membranes in pituitary vs 
24% in islets; Persaud and Jones, unpublished). 
The PMA-induced translocation of PKC activity 
in electrically permeabilised islets incubated in a 
sub-stimulatory concentration of Ca’+ is in accor- 
dance with previous reports that phorbol esters, by 
activating PKC, stimulate insulin secretion from 
permeabilised islets [7,17]. Furthermore, maintain- 
ing intracellular Ca2+ at a sub-stimulatory concen- 
tration and introducing protease inhibitors into the 
permeabilised cells enhanced the recovery of PKC 
activity from permeabilised islets compared to in- 
tact islets, perhaps suggesting that membrane- 
associated PKC is susceptible to proteolytic 
degradation by a Ca2+ -activated protease in islets, 
as has previously been reported in other tissues [2]. 
The cholinergic muscarinic agonist, CCh, pro- 
moted translocation of PKC from cytosol to mem- 
branes in intact islets, as has also been recently 
reported in studies using rat insulinoma cells [16] 
and, in a preliminary report, a hamster cell line 
[ 181. These observations concur with the known ef- 
fects of cholinergic agonists to promote DAG for- 
mation in islet membranes [19], and intact islets 
[20], and suggest hat the DAG thus formed is in- 
volved in the activation and translocation of PKC. 
There have been several demonstrations that 
glucose stimulates the breakdown of inositol 
phospholipids in pancreatic islets with the subse- 
quent generation of inositol phosphates and, 
presumably, DAG [21,22]. Furthermore, there is 
evidence that glucose stimulates the de novo syn- 
thesis of DAG in islets [20]. Despite this, we were 
unable to detect an effect of glucose on PKC 
translocation under conditions in which both PMA 
and CCh produced significant changes in the 
distribution of the enzyme, and in which glucose 
stimulated insulin secretion. It is possible that 
glucose activates only a minority subspecies of 
PKC within B cells and that translocation of this 
minority species is not detectable in the present 
assay which measures the total activity of all PKC 
subspecies. Alternatively, glucose may activate, 
either by DAG or by some other activator [l], an 
isoform of PKC which does not translocate to 
membranes upon activation. However, the most 
likely explanation for our results is that the DAG 
generated in response to glucose does not activate 
PKC, perhaps because of its cellular localisation, 
and that the translocation of PKC is not obligatory 
for glucose-induced insulin secretion. 
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